Canaccord analyst Richard Close raised the firm’s price target on HealthStream to $26 from $23 and keeps a Hold rating on the shares. The analyst noted they reported a quarter that beat both our revenue and adjusted-EBITDA estimates and 2023 initial guidance was mixed with revenue growth of 4-6% estimate but missing consensus but adjusted-EBITDA above our prior forecast.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HSTM: